Listing 1 - 10 of 19 | << page >> |
Sort by
|
Choose an application
Physical activity and exercise were receiving a great attention as a strategy of prevention and treatment of affective and some anxiety disorders. Many studies have showed the efficacy of exercise in major depression and at depressed episode of bipolar patients, as well as, some authors shows the benefits of exercise in some anxiety disorders like Generalized Anxiety Disorder and Panic. Despite their efficacy, little is known concerning the main mechanisms related to the antidepressant and anxiolytic effects of exercise. Several studies in an animal model using Neurotrophic Factors, Oxidative Stress, Immunologic response and other biological markers reveal promising results. However, few studies were conducted in clinical samples. Additional to the antidepressant and anxiolytic effects, exercise appears improve QoL in major depressed, bipolar and anxiety patients. Theoretically, this increase may be associated with cognitive improvements, improvements at sleep quality, physical functioning, as well as other psychological issues as self-esteem, self-concept, and general well-being. The propose of this topic is to address the novelty and most recent research, related to antidepressant and anxiolytic effects of physical activity and exercise in patients with affective and anxiety disorders, as well as the issues associated with QoL improvement.The topic is looking for: – Clinical trials using exercise and physical activity as a treatment affective and anxiety disorders. – Studies investigating the optimal prescription factors (dose, volume, intensity, setting, frequency) associated with antidepressant and anxiolytic effects of physical activity and exercise for affective and anxiety disorder patients. – Original studies, comprehensive reviews, hypothesis and opinions concerning the mechanisms of antidepressant and anxiolytic effects of physical activity and exercise in affective and anxiety disorder patients. – Original studies, comprehensive reviews, hypothesis and opinions concerning other benefits of physical activity and exercise like : cognition, weight gain prevention and QoL in affective and anxiety disorder patients. – Translational research. – Studies of cost-efficacy analysis
Meditative movement --- Galanin --- BDNF --- Quality of Life --- Depression --- Anxiety --- bipolar --- genetic marker --- Meditative movement --- Galanin --- BDNF --- Quality of Life --- Depression --- Anxiety --- bipolar --- genetic marker
Choose an application
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
Science: general issues --- Neurosciences --- neurotrophic factors --- BDNF (brain-derived neurotrophic factor) --- NGF (nerve growth factor) --- CNS—central nervous system --- neuronal plasticity --- neurotrophic factors --- BDNF (brain-derived neurotrophic factor) --- NGF (nerve growth factor) --- CNS—central nervous system --- neuronal plasticity
Choose an application
Brain derived neurotophic factor (BDNF) and its receptor tropomyosin receptor kinase B (TrkB) signaling has been extensively studied for its roles in the central nervous system (CNS) ranging from cell survival, axonal and dendritic growth and synapse formation. Intracellular signaling pathways triggered by BDNF activate gene transcription, translation, post-translational functions, trafficking of key synaptic proteins, and synaptic release mechanism. BDNF-TrkB signaling mediates long-lasting activity-modulated synaptic changes on excitatory and inhibitory neurons and plays significant roles in circuit development and modulation. Furthermore, this pathway is critical for learning, memory, sensory processing and other cognitive functions, and is implicated in neurological and psychiatric diseases. In addition to BDNF, more recent studies have identified new “growth” factors that play important roles in the development, maturation and maintenance and modulation of synaptic function. However, details of the cytoplamic signaling systems downstream of these synaptogenic factors are often less understood than conventional neurotophin signaling. This e-Book has collected original studies and review articles that present cellular and molecular mechanisms concerning activity-dependent synapse formation and their implications for behavior and brain disorders. It is our hope that readers will perceive this volume as a showcase for diversity and complexity of synaptogenic growth factors, and will stimulate further studies in this field.
Molecular biology. --- Molecular biochemistry --- Molecular biophysics --- Biochemistry --- Biophysics --- Biomolecules --- Systems biology --- netrin --- neuropsychiatric disease --- adult neurogenesis --- FGF7 --- lipid raft --- BDNF --- Leptin --- Rho GTPase --- synapse formation --- FGF22
Choose an application
Highly emotional events tend to be well remembered. The adaptive value in this is clear – those events that have a bearing on survival should be stored for future use as long-term memories whereas memories of inconsequential events would not as likely contribute to future survival. Enduring changes in the structure and function of synapses, neural circuitry, and ultimately behavior, can be modulated by highly aversive or rewarding experiences. In the last decade, the convergence of cellular, molecular, and systems neuroscience has produced new insights into the biological mechanisms that determine whether a memory will be stored for the long-term or lost forever. This Research Topic brings together leading experts, who work at multiple levels of analysis, to reveal recent discoveries and concepts regarding the synaptic mechanisms of consolidation and extinction of emotionally arousing memories.
Synapses. --- Neurology --- Memory, Long-Term --- Synapses --- Brain Stimulation --- Amygdala --- BDNF --- PDE4 --- reconsolidation --- Fear conditioning --- posttraumatic stress disorder --- ubiquitin-proteasome system --- CREB --- extinction --- Sleep --- gamma oscillations --- Research. --- physiology. --- Brain Stimulation --- Amygdala --- BDNF --- PDE4 --- reconsolidation --- Fear conditioning --- posttraumatic stress disorder --- ubiquitin-proteasome system --- CREB --- extinction --- Sleep --- gamma oscillations
Choose an application
The prefrontal cortex (PFC) plays a pivotal role in regulating our emotions. The importance of ventromedial regions in emotion regulation, including the ventral sector of the medial PFC, the medial sector of the orbital cortex and subgenual cingulate cortex, have been recognized for a long time. However, it is increasingly apparent that lateral and dorsal regions of the PFC, as well as neighbouring dorsal anterior cingulate cortex, also play a role. Defining the underlying psychological mechanisms by which these functionally distinct regions modulate emotions and the nature and extent of their interactions is a critical step towards better stratification of the symptoms of mood and anxiety disorders. It is also important to extend our understanding of these prefrontal circuits in development. Specifically, it is important to determine whether they exhibit differential sensitivity to perturbations by known risk factors such as stress and inflammation at distinct developmental epochs. This Special Issue brings together the most recent research in humans and other animals that addresses these important issues, and in doing so, highlights the value of the translational approach.
norepinephrine --- medial prefrontal cortex --- fear extinction --- emotion regulation --- emotion processing --- connectivity --- anticipatory arousal --- Pavlovian --- triadic neural systems model --- prelimbic --- development --- positive and negative --- rat --- Williams Syndrome --- psychological treatment --- glia density --- anxiety --- fMRI --- area 25 --- anhedonia --- adolescence --- adolescent --- autonomic --- amygdala --- neuron density --- neural --- prefrontal cortex --- reliability --- functional magnetic resonance imaging (fMRI) --- networks --- cAMP --- cognitive control --- extinction --- infralimbic --- NMDA --- reward --- calcium --- stress adolescence --- BDNF --- machine learning --- negative affect --- hierarchical control --- emotion --- occasion setting --- serotonin transporter --- ventromedial prefrontal cortex --- psychophysiology --- depression --- aging --- dopamine --- age
Choose an application
From an evolutionary perspective, our species has relied upon physical activity for most of its history to survive and has had to escape from predators, to scavenge for food, and to use physique to work or build necessary means for everyday life. Physical activity has been part of our evolution and progress since the very beginning and, consequently, our entire body has been programmed to be active physically. In the last 20 years, scientific research has increasingly shown that our ancient survival principle has beneficial effects not only on the cells and organs involved in physical activities but on the metabolism of the entire organism, influencing the homeostasis and integration of all bodily functions, likely stimulating the production of hormones and other regulatory molecules, with each affecting vital signalling pathways. Most of the web of factors involved in molecular signalling upon exercise are suspected to be centrally controlled by the brain, which has been reported to be deeply modified by physical activity. Such complexity requires a multifaceted approach to shed light on the molecular interactions that occur between physical activity and its outcome at a cellular level.
TFRC --- single nucleotide polymorphism --- high-density lipoprotein --- blood cell counts --- epigenetics --- intestinal microbiome --- iron metabolism --- Irisin --- exercise and health --- healthy lifestyle --- physical exercise --- single nucleotide polymorphisms --- Taiwan biobank --- obesity --- glucokinase-regulator --- ?-actinin --- body mass index --- hepatic lipase --- Taiwan Biobank --- genotyping --- myokines --- DNA-methylation --- NK --- brain health --- gene expression --- ferritin --- exercise and aging --- exercise --- endurance --- antihypertensive therapy --- genetics --- gut microbiome --- ketogenic diet --- inflammation --- PCBP1 --- PCBP2 --- marathon runners --- natural killer cell --- behavior --- aerobic exercise --- exercise and neurodegeneration --- BDNF --- gut microbiota --- physical activity --- performance --- lactate --- sport --- ketogenic diet and fat --- body fat
Choose an application
Over the years, there has been increasing interest into the public health impact of cannabis use, especially by young adults. This follows the evidence of a growing prevalence of regular cannabis use worldwide, with approximately 200 million users. Recreational cannabis use, especially a frequent use of products with high levels of its main psychoactive ingredient delta-9-tetrahydrocannabinol (Δ 9-THC), can cause dependence and have transient and long-lasting detrimental mental health effects, also negatively impacting cognitive processing and brain function and metabolism. In regular users, the development of tolerance to some of the effects of cannabis, especially the pleasurable ones, may lead to progressively heavier use in order to obtain the same effects in terms of their intensity, with higher health risks. However, the Cannabis Sativa plant contains different chemicals with different potential effects. In this regard, cannabidiol has gained interest because of its potential therapeutic properties, in line with evidence that CBD and Δ9-THC may exhibit opposite effects at the cannabinoid receptor type 1 (CB1), Δ9-THC being a partial agonist and CBD an antagonist/inverse agonist. Different cannabinoids may modulate human brain function and behavior in different ways, with different risk–benefit profiles.
Medicine --- Neurosciences --- delta-9-tetrahydrocannabinol --- placebo --- cannabis-associated psychosis --- schizophrenia --- BDNF --- CB1 --- CB2 --- episodic memory --- exercise --- African American --- black --- older adult --- marijuana use --- cannabis use disorder --- cue reactivity --- craving --- inhibitory control --- frontal alpha asymmetry --- EEG --- cannabinoids --- cannabis use --- psychotic disorder --- genetics --- age of onset --- clinical high risk --- cannabis --- memory --- functional magnetic resonance imaging --- THC --- systematic review --- gyrification --- surface area --- cortical surface structure --- aerobic fitness --- gender --- endocannabinoid system --- executive functions --- problematic cannabis use --- triple network --- EEG functional connectivity --- eLORETA --- resting state --- Delta-9-tetrahydrocannabinol --- dronabinol --- marijuana --- randomized controlled trial --- opioids --- traumatic injury --- alcohol --- adolescents --- fMRI --- interoception --- negative reinforcement --- migraine: chronic pain --- triptans --- disability
Choose an application
This book focuses of the neurotransmission phenomenon. By definition, neurotransmitters are chemicals that enable communication, i.e., the flow of nerve impulses between nerve cells or between nerve cells and muscles and glands. Recently, one can distinguish excitatory and inhibitory mediators, both of which are endo–exogenous compounds that control the function of the whole organism. From a chemical point of view, neurotransmitters belong to many different structural groups, such as amino acids (such as glycine), peptides (such as substance P, somatostatin), monoamines (such as noradrenaline or dopamine), purine derivatives (such as adenosine), gases (such as nitrogen, NO, carbon monoxide CO), and acetylcholine. From a medical point of view, disturbances in the concentration of neurotransmitters in the body result in the occurrence of mental disorders and diseases (such as depression, schizophrenia, Parkinson’s disease) and contribute to the occurrence of dementia (including Alzheimer’s disease), among other diseases. However, the problem is much wider. These disorders can lead to a number of cardiovascular diseases and can lead to the development of vascular diseases of the brain as well as in many other organs. Therefore, pharmacological intervention is a therapy that tries to interfere with regulatory processes year after year. Such treatments improve survival, reduce the frequency of readmission, and improve patients' quality of life.
Research & information: general --- Chemistry --- white matter hyperintensities --- dysautonomia --- genetic polymorphisms --- dementia --- levodopa --- renin-angiotensin system --- orthostatic hypotension --- reserpine-induced fibromyalgia model --- vortioxetine --- ropinirole --- serotonin and dopamine in fibromyalgia --- mouse --- dopamine --- acetylcholine --- glutamate --- BDNF --- serotonin --- neurotransmitters --- statins --- neurodegenerative diseases --- stroke --- depression --- androgenetic alopecia --- 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors --- mixed dyslipidemia --- risk factors --- halogenated pyrazolines --- monoamine oxidase inhibitors --- kinetics --- reversibility --- molecular dynamics --- guanylate cyclase (GC) --- chronic heart failure (CHF) --- pulmonary arterial hypertension (PAH) --- tiagabine --- cardiac voltage-gated ion channels --- molecular modeling --- ECG study --- SGLT2i --- sodium-glucose cotransporter 2 inhibitors --- neuroprotection --- atheroprotection --- mTOR --- type 2 diabetes mellitus --- cognitive impairment --- inflammation --- oxidative stress --- antibiotics --- neurotoxicity --- adverse drug reaction --- neurotransmission --- 5-HT receptors --- gastrointestinal tract --- white matter hyperintensities --- dysautonomia --- genetic polymorphisms --- dementia --- levodopa --- renin-angiotensin system --- orthostatic hypotension --- reserpine-induced fibromyalgia model --- vortioxetine --- ropinirole --- serotonin and dopamine in fibromyalgia --- mouse --- dopamine --- acetylcholine --- glutamate --- BDNF --- serotonin --- neurotransmitters --- statins --- neurodegenerative diseases --- stroke --- depression --- androgenetic alopecia --- 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors --- mixed dyslipidemia --- risk factors --- halogenated pyrazolines --- monoamine oxidase inhibitors --- kinetics --- reversibility --- molecular dynamics --- guanylate cyclase (GC) --- chronic heart failure (CHF) --- pulmonary arterial hypertension (PAH) --- tiagabine --- cardiac voltage-gated ion channels --- molecular modeling --- ECG study --- SGLT2i --- sodium-glucose cotransporter 2 inhibitors --- neuroprotection --- atheroprotection --- mTOR --- type 2 diabetes mellitus --- cognitive impairment --- inflammation --- oxidative stress --- antibiotics --- neurotoxicity --- adverse drug reaction --- neurotransmission --- 5-HT receptors --- gastrointestinal tract
Choose an application
The focus of this Special Issue is “Nutrition and the Central Nervous System”. The brain is, as a very specialized and one of the most metabolically active organs of the body, dependent on a steady and sufficient supply of dietary ingredients. The critical role of the diet for brain development as well as for proper CNS functioning and the possible preventative roles against neurodegenerative and neurological conditions is commonly accepted. The overarching aim of this Special Issue is pinpointing the mechanisms of action and publishing state-of-the-art contributions discussing the roles that nutritional compounds play in the development, maintenance, and aging of the CNS.
Research & information: general --- Biology, life sciences --- Food & society --- dipeptide --- dopamine --- hippocampus --- memory --- monoamine oxidase B --- milk --- hypothalamus --- nucleus accumbens --- reward --- appetite --- palatability --- major depressive disorder --- Chinese herbal formula --- corticosterone --- BDNF --- oxidative stress --- probiotics --- microbiota --- beneficial bacteria --- psychobiotics --- human health --- neurodegenerative diseases --- neuroinflammation --- apoptosis --- synaptic dysfunction --- IRS1 --- serine phosphorylation --- diabetes --- aging --- Alzheimer’s disease --- memory decline --- Aβ --- AMPK --- energy depletion --- S-equol --- 17β-estradiol --- estrogen receptor alpha --- cell cycle --- β-Amyloid --- microbiome --- microbiota-gut-brain axis --- ADHD --- attention-deficit-hyperactive-disorder --- Angelica gigas --- mild cognitive impairment --- traumatic brain injury --- chronic mild stress --- children --- cingulum --- development --- dietary sugar --- fructose --- dipeptide --- dopamine --- hippocampus --- memory --- monoamine oxidase B --- milk --- hypothalamus --- nucleus accumbens --- reward --- appetite --- palatability --- major depressive disorder --- Chinese herbal formula --- corticosterone --- BDNF --- oxidative stress --- probiotics --- microbiota --- beneficial bacteria --- psychobiotics --- human health --- neurodegenerative diseases --- neuroinflammation --- apoptosis --- synaptic dysfunction --- IRS1 --- serine phosphorylation --- diabetes --- aging --- Alzheimer’s disease --- memory decline --- Aβ --- AMPK --- energy depletion --- S-equol --- 17β-estradiol --- estrogen receptor alpha --- cell cycle --- β-Amyloid --- microbiome --- microbiota-gut-brain axis --- ADHD --- attention-deficit-hyperactive-disorder --- Angelica gigas --- mild cognitive impairment --- traumatic brain injury --- chronic mild stress --- children --- cingulum --- development --- dietary sugar --- fructose
Choose an application
This book is focused on the existing gap between the theoretical bioactivity of (poly)phenols and their real influence in terms of health, once ingested. Due to this, new studies are needed and some examples of new tendencies are included from in vitro and in vivo models which allow for exploring bioaccessibility, bioavailability, and bioactivity, that need to be developed to understand the actual importance of consuming functional foods, rich in these plant secondary metabolites. Moreover, current new strategies need to be developed to enhance the content of these foods, as well as setting up new formulations rich in bioaccessible and bioavailable compounds. Altogether, it could provide a new perspective in therapy, expanding the use of these natural functional compounds, ingredients, and foods in the clinical frame, reducing the use of synthetic drugs. As a result, the joint contribution of multidisciplinary experts from the areas of food science, health, and nutrition, together with the industrial sector, would help to reach these objectives. Taking this into account, diverse studies have been included in this study, which comprises different strategies to approach these objectives from different, complementary, points of view, ranging from the enrichment of by-products in bioactive compounds, through different agricultural techniques, to the assimilation of these compounds by the human body, both in vitro and in vivo, as well as by clinical studies.
Research & information: general --- Biology, life sciences --- Food & society --- cognitive function --- polyphenols --- flavonoids --- CREB protein --- BDNF --- memory --- fruits and vegetables --- cerebral blood flow --- polydatin --- resveratrol --- urate crystals --- pyrophosphate crystals --- crystal-induced inflammation --- dietary intervention --- maqui-citrus juice --- flavanones --- urinary excretion --- UHPLC-ESI-QqQ-MS/MS --- obesity --- Hibiscus sabdariffa --- Lippia citriodora --- olive --- salinity --- osmolytes --- adaptation --- secondary metabolism --- plant growth promoting rhizobacteria (PGPR) --- net photosynthesis --- oleuropein --- water use efficiency (WUE) --- phenolic compounds --- HPLC-DAD --- fluorescence detection --- flavan-3-ols --- procyanidins --- ORAC --- (+)-catechin --- (−)-epicatechin --- dark chocolate --- cranberry --- periodontal diseases --- dental biofilm --- antibacterial activity --- anti-biofilm activity --- F. nucleatum --- P. gingivalis --- A. actinomycetemcomitans --- (poly)phenols --- bioactivity --- bioavailability --- inflammation --- secondary metabolites --- antibacterial --- antioxidant --- diet --- fruit --- vegetables --- cognitive function --- polyphenols --- flavonoids --- CREB protein --- BDNF --- memory --- fruits and vegetables --- cerebral blood flow --- polydatin --- resveratrol --- urate crystals --- pyrophosphate crystals --- crystal-induced inflammation --- dietary intervention --- maqui-citrus juice --- flavanones --- urinary excretion --- UHPLC-ESI-QqQ-MS/MS --- obesity --- Hibiscus sabdariffa --- Lippia citriodora --- olive --- salinity --- osmolytes --- adaptation --- secondary metabolism --- plant growth promoting rhizobacteria (PGPR) --- net photosynthesis --- oleuropein --- water use efficiency (WUE) --- phenolic compounds --- HPLC-DAD --- fluorescence detection --- flavan-3-ols --- procyanidins --- ORAC --- (+)-catechin --- (−)-epicatechin --- dark chocolate --- cranberry --- periodontal diseases --- dental biofilm --- antibacterial activity --- anti-biofilm activity --- F. nucleatum --- P. gingivalis --- A. actinomycetemcomitans --- (poly)phenols --- bioactivity --- bioavailability --- inflammation --- secondary metabolites --- antibacterial --- antioxidant --- diet --- fruit --- vegetables
Listing 1 - 10 of 19 | << page >> |
Sort by
|